Menovazin

INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT MENOVAZINE

Composition:

Active substances: menthol, procaine hydrochloride (novocaine), benzocaine (anesthesin);

100 ml of solution contains 2.5 g of menthol, 1 g of procaine hydrochloride (novocaine), 1 g of benzocaine (anesthesin);

Excipient: ethanol 70%.

Pharmaceutical form. Topical alcoholic solution.

Main physicochemical properties: clear, colorless liquid with a menthol odor.

Pharmacotherapeutic group.

Agents applied locally for joint and muscle pain.

ATC code M02AX.

Pharmacological properties.

Pharmacodynamics.

The drug has anti-pruritic and local anesthetic effects. When applied to the skin and mucous membranes, it stimulates nerve endings, causing sensations of cold, mild burning, and tingling.

It exerts a mild analgesic effect.

Pharmacokinetics.

When applied locally, the drug does not enter the bloodstream.

Clinical characteristics.

Indications.

The drug is indicated for neuralgias, myalgias, and arthralgias.

Contraindications.

The drug is contraindicated in cases of hypersensitivity to procaine and to other components of the drug.

Special precautions.

Do not apply to damaged skin or skin with allergic manifestations. Do not apply to facial skin.

The recommended application guidelines for the medicinal product must not be violated, as this may harm health.

Interaction with other medicinal products and other forms of interaction.

Components of the drug (procaine, anestezin) reduce the antibacterial effect of sulfonamide drugs. They enhance the effects of drugs with local anesthetic action.

When using any other medicinal products concurrently, inform the physician.

Special precautions for use.

Use during pregnancy or breastfeeding.

During pregnancy or breastfeeding, the use of this medicinal product is only possible if the expected benefit to the mother outweighs the potential risk to the fetus or infant.

Ability to affect driving performance or operating machinery.

Has no effect.

Method of Administration and Dosage

The medication is intended for external use. Rub the painful skin areas with Menovazin 2–3 times daily. The duration of treatment depends on the form and severity of the disease, the drug's effect, and the type of therapy (monotherapy or in combination with other medicinal agents).

Children

Do not use in children under 12 years of age.

Overdose

With prolonged use, dizziness, general weakness, decreased arterial pressure, and allergic reactions may occur. If such symptoms occur, discontinue the medication, wash the residual product from the skin surface with water, and administer symptomatic therapy.

Side effects.

Allergic reactions are possible (hyperemia, skin irritation, itching sensation, rash, swelling, urticaria).

If any adverse events occur, consult a physician.

Shelf life. 2 years.

The product must not be used after the expiry date stated on the packaging.

Storage conditions.

Store in the original packaging at a temperature not exceeding 25 °C.

Keep out of reach of children.

Packaging.

40 ml or 100 ml in glass or polymer bottles.

Prescription status. Over-the-counter.

Manufacturer.

LLC "MEDLEV".

Manufacturer's address.

171 Bohdana Khmelnytskoho St. (building B-1, K-1), Dnipro, Ukraine, 49000.